ACTA MEDICA MEDITERRANEA, vol.37, no.1, pp.495-500, 2021 (SCI-Expanded)
Introduction: The aim of this study is to determine the expression level of lipocalin-2 protein in human lung adenocarcinom tissues and to evaluate the relationship between its expression levels and clinicopathological parameters, including response to pemetrexed, degree of tumor differentiation, driver mutation status, progression free survival (PFS) and overall survival (OS).